BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 12692611)

  • 21. The efficacy of two different oral hygiene regimens on the incidence and severity of oral mucositis in pediatric patients receiving hematopoietic stem cell transplantation: A prospective interventional study.
    Mubaraki S; Pani SC; Alseraihy A; Abed H; Alkhayal Z
    Spec Care Dentist; 2020 Nov; 40(6):566-573. PubMed ID: 32964512
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Low-energy laser therapy for prevention of oral mucositis in hematopoietic stem cell transplantation.
    Jaguar GC; Prado JD; Nishimoto IN; Pinheiro MC; de Castro DO; da Cruz Perez DE; Alves FA
    Oral Dis; 2007 Nov; 13(6):538-43. PubMed ID: 17944669
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Implementation of a standardized protocol for prevention and management of oral mucositis in patients undergoing hematopoietic cell transplantation.
    Bhatt V; Vendrell N; Nau K; Crumb D; Roy V
    J Oncol Pharm Pract; 2010 Sep; 16(3):195-204. PubMed ID: 19910393
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The impact of concurrent granulocyte macrophage-colony stimulating factor on radiation-induced mucositis in head and neck cancer patients: a double-blind placebo-controlled prospective phase III study by Radiation Therapy Oncology Group 9901.
    Ryu JK; Swann S; LeVeque F; Scarantino CW; Johnson D; Chen A; Fortin A; Pollock J; Kim H; Ang KK
    Int J Radiat Oncol Biol Phys; 2007 Mar; 67(3):643-50. PubMed ID: 17293228
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effectiveness of transdermal fentanyl patch for treatment of acute pain due to oral mucositis in patients receiving stem cell transplantation.
    Kim JG; Sohn SK; Kim DH; Baek JH; Chae YS; Bae NY; Kim SY; Lee KB
    Transplant Proc; 2005 Dec; 37(10):4488-91. PubMed ID: 16387151
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Predictors of oral mucositis in patients receiving hematopoietic cell transplants for chronic myelogenous leukemia.
    Robien K; Schubert MM; Bruemmer B; Lloid ME; Potter JD; Ulrich CM
    J Clin Oncol; 2004 Apr; 22(7):1268-75. PubMed ID: 15051775
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Caphosol, a therapeutic option in case of cancer therapy-induced oral mucositis in children? : Results from a prospective multicenter double blind randomized controlled trial.
    Raphael MF; den Boer AM; Kollen WJ; Mekelenkamp H; Abbink FC; Kaspers GJ; Zomer-Kooijker K; Molmans BH; Tissing WJ
    Support Care Cancer; 2014 Jan; 22(1):3-6. PubMed ID: 24197056
    [No Abstract]   [Full Text] [Related]  

  • 28. The Prospective Oral Mucositis Audit: relationship of severe oral mucositis with clinical and medical resource use outcomes in patients receiving high-dose melphalan or BEAM-conditioning chemotherapy and autologous SCT.
    McCann S; Schwenkglenks M; Bacon P; Einsele H; D'Addio A; Maertens J; Niederwieser D; Rabitsch W; Roosaar A; Ruutu T; Schouten H; Stone R; Vorkurka S; Quinn B; Blijlevens N;
    Bone Marrow Transplant; 2009 Jan; 43(2):141-7. PubMed ID: 18776926
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Reliability and validity of a patient self-administered daily questionnaire to assess impact of oral mucositis (OM) on pain and daily functioning in patients undergoing autologous hematopoietic stem cell transplantation (HSCT).
    Stiff PJ; Erder H; Bensinger WI; Emmanouilides C; Gentile T; Isitt J; Lu ZJ; Spielberger R
    Bone Marrow Transplant; 2006 Feb; 37(4):393-401. PubMed ID: 16415901
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The influence of palifermin (Kepivance) on oral mucositis and acute graft versus host disease in patients with hematological diseases undergoing hematopoietic stem cell transplant.
    Nasilowska-Adamska B; Rzepecki P; Manko J; Czyz A; Markiewicz M; Federowicz I; Tomaszewska A; Piatkowska-Jakubas B; Wrzesien-Kus A; Bieniaszewska M; Duda D; Szydlo R; Halaburda K; Szczepinski A; Lange A; Hellman A; Robak T; Skotnicki A; Jedrzejczak WW; Walewski J; Holowiecki J; Komarnicki M; Dmoszynska A; Warzocha K; Marianska B
    Bone Marrow Transplant; 2007 Nov; 40(10):983-8. PubMed ID: 17846600
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A pilot randomized controlled trial of an oral care intervention to reduce mucositis severity in stem cell transplant patients.
    Salvador P; Azusano C; Wang L; Howell D
    J Pain Symptom Manage; 2012 Jul; 44(1):64-73. PubMed ID: 22672917
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Sucralfate mouthwash for prevention and treatment of 5-fluorouracil-induced mucositis: a randomized, placebo-controlled trial.
    Nottage M; McLachlan SA; Brittain MA; Oza A; Hedley D; Feld R; Siu LL; Pond G; Moore MJ
    Support Care Cancer; 2003 Jan; 11(1):41-7. PubMed ID: 12527953
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Oral mucositis-related oropharyngeal pain and correlative tumor necrosis factor-alpha expression in adult oncology patients undergoing hematopoietic stem cell transplantation.
    Fall-Dickson JM; Ramsay ES; Castro K; Woltz P; Sportés C
    Clin Ther; 2007; 29 Suppl():2547-61. PubMed ID: 18164921
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Caphosol for prevention of oral mucositis in pediatric myeloablative haematopoietic cell transplantation.
    Treister N; Nieder M; Baggott C; Olson E; Chen L; Dang H; Krailo M; August A; Sung L
    Br J Cancer; 2017 Jan; 116(1):21-27. PubMed ID: 27875526
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Treating oral mucositis with a supersaturated calcium phosphate rinse: comparison with control in patients undergoing allogeneic hematopoietic stem cell transplantation.
    Markiewicz M; Dzierzak-Mietla M; Frankiewicz A; Zielinska P; Koclega A; Kruszelnicka M; Kyrcz-Krzemien S
    Support Care Cancer; 2012 Sep; 20(9):2223-9. PubMed ID: 22736463
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Treatment of oral mucositis after peripheral blood SCT with ATL-104 mouthwash: results from a randomized, double-blind, placebo-controlled trial.
    Hunter A; Mahendra P; Wilson K; Fields P; Cook G; Peniket A; Crawley C; Hickling R; Marcus R
    Bone Marrow Transplant; 2009 Apr; 43(7):563-9. PubMed ID: 18997832
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A prospective randomized double-blind trial of antithrombin III concentrate in the treatment of multiple-organ dysfunction syndrome during hematopoietic stem cell transplantation.
    Haire WD; Ruby EI; Stephens LC; Reed E; Tarantolo SR; Pavletic ZS; Bierman PJ; Bishop M; Kessinger A; Vose J; Armitage JO
    Biol Blood Marrow Transplant; 1998; 4(3):142-50. PubMed ID: 9923412
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Oral hygiene regimens, plaque control, and gingival health: a two-month clinical trial with antimicrobial agents.
    Biesbrock AR; Bartizek RD; Gerlach RW; Terézhalmy GT
    J Clin Dent; 2007; 18(4):101-5. PubMed ID: 18277739
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A phase Ib clinical trial of PV701, a milk-derived protein extract, for the prevention and treatment of oral mucositis in patients undergoing high-dose BEAM chemotherapy.
    Prince HM; Regester G; Gates P; Jablonskis L; Seymour JF; Lillie K; West R; Wolf M; Januszewicz H; Belford D
    Biol Blood Marrow Transplant; 2005 Jul; 11(7):512-20. PubMed ID: 15983551
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Chemotherapy: the effect of oral cryotherapy on the development of mucositis.
    Karagözoğlu S; Filiz Ulusoy M
    J Clin Nurs; 2005 Jul; 14(6):754-65. PubMed ID: 15946284
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.